STOCK TITAN

Myriad Genetics to Host Investor Day on September 19, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Myriad Genetics, Inc. will host an Investor Day at the Dr. Walter Gilbert Innovation Center on September 19, 2023. The event will include a facility tour, presentations on commercialization strategies and clinical advancement, and a Q&A session. A live webcast will be available for remote attendees.
Positive
  • None.
Negative
  • None.

SALT LAKE CITY, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an Investor Day at the newly constructed Dr. Walter Gilbert Innovation Center in South San Francisco on September 19, 2023. The in-person event will commence with a facility tour beginning at 9:00 am PDT. The Investor Day presentation and Q&A will take place from 10:00 am to 12:00 pm PDT (1:00 pm to 3:00 pm EDT).

President and CEO Paul J. Diaz and other members of the Myriad executive leadership team will discuss commercialization strategies, clinical advancement and new product pipeline, and long-term financial goals.

For those unable to attend in person, a live webcast of the Investor Day presentation and Q&A will be available at www.investor.myriad.com. A replay will be posted on Myriad Genetics’ website after the event and will be available for at least 30 days following.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Media Contact:
Glenn Farrell
(801) 584-1153
Glenn.Farrell@myriad.com

Investor Contact:
Matt Scalo
(801) 584-3532
Matt.Scalo@myriad.com


FAQ

When and where will Myriad Genetics host the Investor Day?

Myriad Genetics will host the Investor Day at the Dr. Walter Gilbert Innovation Center in South San Francisco on September 19, 2023.

Who will be presenting at the Investor Day?

President and CEO Paul J. Diaz and other members of the Myriad executive leadership team will be presenting at the Investor Day.

What topics will be discussed at the Investor Day?

The Investor Day will cover commercialization strategies, clinical advancement, new product pipeline, and long-term financial goals.

Will there be a webcast available for remote attendees?

Yes, a live webcast of the Investor Day presentation and Q&A will be available at www.investor.myriad.com.

Will there be a replay available for those unable to attend?

Yes, a replay of the Investor Day presentation will be posted on Myriad Genetics' website and will be available for at least 30 days following the event.

Myriad Genetics Inc

NASDAQ:MYGN

MYGN Rankings

MYGN Latest News

MYGN Stock Data

1.41B
89.02M
2.02%
102.23%
4.94%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
SALT LAKE CITY